VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KINSKingstone Companies, Inc.
$18.19$263M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksKINSFinancials

Kingstone Companies, Inc. (KINS) Financials

30Y historyFree accessUpdated daily

Revenue growth remains robust at 28.39% year-over-year, though underwriting profitability is inconsistent, evidenced by a combined ratio that spiked to 112.4% in 2026Q1.

KINS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue208.47M199.19M155.14M144.19M130.16M161.23M131.37M145.12M113.77M92.77M77.44M64.18M50.05M36.57M29.08M27.69M21.6M8.39M429.64K649.25K7.12M12.02M15.09M8.69M3.78M2.62M7.82M9.07M1.03M996.62K1.12M
Revenue Growth %22.72%28.39%7.6%10.78%-19.27%22.73%-9.48%27.55%22.64%19.8%20.66%28.22%36.88%25.75%5%28.23%157.38%1852.98%-33.82%-90.88%-40.74%-20.34%73.71%129.56%44.68%-66.54%-13.82%-3.45%-10.91%9.24%
Medical Costs & Claims93.37M84.27M96.56M116.21M122.97M135.09M98.26M120.28M83.64M55.37M46.12M38.5M29.16M22.95M18.48M14.8M000000000826.28K1.3M1.44M19.57K23.2K14.29K
Medical Cost Ratio %44.79%42.3%62.24%80.6%94.48%83.78%74.8%82.88%73.51%59.68%59.55%59.99%58.26%62.76%63.56%53.45%0%0%0%0%0%0%0%0%0%31.59%16.67%15.92%1.9%2.33%1.28%
Gross Profit115.1M114.93M58.58M27.98M7.19M26.14M33.11M24.84M30.13M37.4M31.32M25.68M20.89M13.62M10.6M12.89M21.6M7.67M911.23K5.75M11.08M13.92M15.09M8.69M3.78M2.69M6.51M7.63M1.01M973.42K1.1M
Gross Margin %55.21%57.7%37.76%19.4%5.52%16.22%25.2%17.12%26.49%40.32%40.45%40.01%41.74%37.24%36.44%46.55%100%91.37%212.09%884.9%155.61%115.83%100%100%100%103.02%83.33%84.08%98.1%97.67%98.72%
Gross Profit Growth %-96.19%109.38%289.24%-72.51%-21.04%33.27%-17.55%-19.43%19.42%21.97%22.9%53.44%28.5%-17.8%-40.31%181.68%741.37%-84.14%-48.16%-20.39%-7.73%73.71%129.56%40.44%-58.63%-14.59%-3.91%-11.86%9.63%
Operating Expenses76.18M63.88M35.29M35.34M35.13M35.55M34.4M32.63M27.13M23.03M17.9M15.37M13.02M10.84M9.53M9.3M19.75M8.61M1.45M2.36M7.55M10.77M13.17M7.43M3.01M2.59M7.73M8.07M1.12M1.11M1.1M
OpEx / Revenue %36.54%32.07%22.75%24.51%26.99%22.05%26.18%22.48%23.84%24.83%23.12%23.95%26.01%29.65%32.76%33.58%91.44%102.6%337.15%363.48%106.08%89.64%87.27%85.54%79.58%98.86%98.87%89.03%108.5%111.72%98.76%
Depreciation & Amortization2.65M2.56M2.45M2.97M3.3M3.29M2.86M2.55M1.79M1.4M1.12M1.03M874.91K646.48K596.35K602.7K615.28K269.09K36.77K121.56K577.06K476.21K484.18K312.19K153.18K293.61K788.26K722K40.49K52.19K51.54K
Combined Ratio %81.33%74.37%84.99%105.11%121.47%105.84%100.98%105.36%97.36%84.51%82.67%83.94%84.27%92.41%96.32%87.03%91.44%102.6%337.15%363.48%106.08%89.64%87.27%85.54%79.58%130.45%115.54%104.95%110.4%114.05%100.04%
Operating Income38.93M51.05M23.29M-7.37M-27.94M-9.41M-1.29M-7.78M3.01M14.37M13.42M10.31M7.88M2.78M1.07M3.59M1.85M-218.51K-1.02M-1.71M-432.75K1.25M1.92M1.26M772.78K-796.42K-1.21M-448.9K-107.25K-140K-443
Operating Margin %18.67%25.63%15.01%-5.11%-21.47%-5.84%-0.98%-5.36%2.64%15.49%17.33%16.06%15.73%7.59%3.68%12.97%8.56%-2.6%-237.15%-263.48%-6.08%10.36%12.73%14.46%20.42%-30.45%-15.54%-4.95%-10.4%-14.05%-0.04%
Operating Income Growth %-119.19%416.18%73.64%-196.96%-630.65%83.45%-358.81%-79.07%7.09%30.16%30.9%183.64%159.59%-70.22%94.21%946.35%78.55%40.44%-295.29%-134.76%-35.19%53.01%62.48%197.03%34.41%-170.49%-23.39%-31502.26%-100.78%
EBITDA41.58M53.61M25.74M-4.39M-24.64M-6.12M1.58M-5.24M4.79M15.77M14.54M11.34M8.75M3.42M1.67M4.19M2.46M50.58K-982.11K-1.59M144.31K1.72M2.41M1.57M925.96K-502.81K-425.99K273.1K-66.76K-87.81K51.1K
EBITDA Margin %19.94%26.91%16.59%-3.05%-18.93%-3.8%1.2%-3.61%4.21%17%18.78%17.67%17.48%9.36%5.73%15.15%11.41%0.6%-228.59%-244.75%2.03%14.32%15.94%18.05%24.47%-19.23%-5.45%3.01%-6.47%-8.81%4.57%
Interest Expense287.76K445.21K3.51M4M2.02M1.83M1.83M1.83M1.82M60.34K00075.73K81.62K120.88K259.38K311.38K337.27K471.35K1.35M1.11M1.26M420.19K64.3K47.43K144.17K0000
Non-Operating Income-217.76K-445.21K-3.51M-4M-2.02M-1.83M-1.83M-1.83M-1.82M0000-75.73K-81.62K-120.88K-259.38K-5.55M-987.43K-1.3M00000000000
Pretax Income38.93M51.05M23.29M-7.37M-27.94M-9.41M-1.29M-7.78M3.01M14.31M13.42M10.31M7.88M2.78M1.07M3.59M1.85M5.02M-368.72K-884.52K305.71K901.76K1.86M1.36M710.95K-1.02M-3.69M-442.8K-107.25K-140K-443
Pretax Margin %18.67%25.63%15.01%-5.11%-21.47%-5.84%-0.98%-5.36%2.64%15.43%17.33%16.06%15.73%7.59%3.68%12.97%8.56%59.83%-85.82%-136.24%4.29%7.5%12.3%15.64%18.79%-39.18%-47.26%-4.88%-10.4%-14.05%-0.04%
Income Tax7.85M10.28M4.93M-1.2M-5.42M-2.03M-2.26M-1.82M-86.18K4.32M4.52M3.35M2.55M764.27K302.91K1.09M767.43K-66.8K-448.2K-419.23K137.57K406K481.4K22.61K10.53K16.91K25K7.24K4.33K3.99K4.66K
Effective Tax Rate %20.17%20.14%21.17%16.25%19.39%21.59%175.51%23.34%-2.87%30.21%33.68%32.49%32.34%27.53%28.32%30.31%41.5%-1.33%121.55%47.4%45%45.02%25.94%1.66%1.48%-1.65%-0.68%-1.63%-4.04%-2.85%-1051.02%
Net Income31.08M40.77M18.36M-6.17M-22.52M-7.38M972.39K-5.97M3.09M9.99M8.9M6.96M5.33M2.01M766.71K2.5M983.14K4.82M-977.21K-47.45K508.38K495.76K1.37M1.29M1.05M-929.55K-3.72M-450.04K-111.58K-143.99K-5.1K
Net Margin %14.91%20.47%11.83%-4.28%-17.31%-4.58%0.74%-4.11%2.72%10.76%11.49%10.84%10.65%5.5%2.64%9.04%4.55%57.45%-227.45%-7.31%7.14%4.12%9.11%14.85%27.64%-35.54%-47.58%-4.96%-10.82%-14.45%-0.46%
Net Income Growth %49.3%122.06%397.62%72.62%-205.28%-858.78%116.3%-292.88%-69.03%12.21%27.88%30.61%164.79%162.46%-69.37%154.61%-79.61%593.33%-1959.66%-109.33%2.55%-63.93%6.56%23.31%212.53%75%-726.21%-22.51%-2723.93%-109.95%
EPS (Diluted)2.152.881.48-0.57-2.12-0.700.09-0.550.290.941.140.940.720.500.200.640.291.62-0.33-0.020.170.170.440.450.45-0.38-1.26-0.19-0.10-0.13-0.01
EPS Growth %35.22%94.59%359.65%73.11%-202.86%-872.63%116.47%-289.66%-69.15%-17.54%21.28%30.56%44%150%-68.75%120.69%-82.1%590.91%-1962.5%-109.41%0%-61.36%-2.22%0%218.42%69.84%-563.16%-23.23%--106%
EPS (Basic)-2.931.60-0.57-2.12-0.700.09-0.550.290.961.150.950.730.510.200.650.291.62-0.33-0.020.180.180.550.500.45-0.38-1.26-0.19-0.10-0.13-0.01
Diluted Shares Outstanding14.45M14.14M12.42M10.76M10.65M10.59M10.73M10.77M10.72M10.58M7.81M7.38M7.36M4.06M3.87M3.92M3.43M2.98M2.97M2.96M3.25M2.92M3.23M2.95M2.41M2.45M2.95M2.35M1.12M1.12M847.24K

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

New York geographic concentration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Aggressive Premium Growth Amid Volatility

According to recent financial disclosures, Kingstone achieved a 28.39% year-over-year revenue growth rate, suggesting that aggressive rate adjustments are successfully penetrating the New York market, though the sustainability of this top-line expansion remains contingent on the company's ability to maintain policy retention in a hardening environment.

The recent acceleration in top-line growth appears to be driven by significant rate increases rather than organic volume expansion. Investors should monitor whether these price hikes eventually lead to adverse selection or a decline in policyholder retention, which would undermine the company's long-term competitive positioning in the tri-state area.

Underwriting Profitability Subject To Swings

Based on reported figures, the combined ratio fluctuated significantly, reaching a peak of 112.4% in 2026Q1, which indicates that underwriting losses are periodically offsetting operational gains and forcing a reliance on investment income to achieve bottom-line profitability during periods of elevated catastrophe-related claims activity.

The volatility in the combined ratio suggests that Kingstone's underwriting results are highly sensitive to weather-related events and potential reserve adjustments. The inability to consistently maintain a combined ratio below 100% implies that the current pricing strategy may not yet fully account for the underlying risk profile of the New York coastal book.

Reserve Development Masks Operational Reality

As reported in financial statements, the dramatic shift in 2025Q4 to a -30.2% loss ratio suggests that prior-year reserve releases are significantly distorting current-period earnings, potentially masking the true underlying underwriting performance and creating a misleading picture of the company's core profitability for the fiscal year.

The extreme variance in loss ratios between quarters warrants further investigation into the actuarial assumptions governing reserve development. Such fluctuations may indicate that the company is either overly conservative in its initial loss estimates or is utilizing reserve releases to smooth earnings during periods of operational stress.

Liquidity Constraints Limit Strategic Flexibility

Based on the provided data, the company's cash position of $12.1 million relative to its quarterly revenue suggests a vulnerable liquidity profile, which may limit management's ability to respond to sudden catastrophe events without potentially liquidating investment assets at unfavorable prices or increasing reliance on external financing.

The low cash-to-revenue ratio appears to be a structural concern for an insurer operating in a high-risk coastal environment. This lack of immediate liquidity may force the company to maintain a more conservative investment posture, potentially limiting the yield-generating capacity of its float and constraining its ability to pursue growth opportunities.

KINS — Frequently Asked Questions

Quick answers to the most common questions about buying KINS stock.

What was Kingstone Companies, Inc.'s (KINS) revenue in 2025?

For fiscal year 2025, Kingstone Companies, Inc. (KINS) reported total revenue of $199.2M. This represents a 17706.6% increase compared to $1.1M in 1996.

Is Kingstone Companies, Inc. (KINS) profitable?

Kingstone Companies, Inc. (KINS) is profitable, generating $40.8M in net income for the fiscal year ending 2025 with a net profit margin of 20.5%.

What is Kingstone Companies, Inc.'s operating profit margin?

Kingstone Companies, Inc. (KINS) reported an operating income of $51.0M, resulting in an operating profit margin of 25.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Kingstone Companies, Inc.'s gross profit and gross margin?

Kingstone Companies, Inc. (KINS) generated $114.9M in gross profit for the year, representing a gross profit margin of 57.7%. This demonstrates the company's core pricing power and production efficiency.